A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities
Clinical trial NCT01101308 · COMPLETED
Trial details
- NCT number
- NCT01101308
- Sponsor
- Purdue Pharma LP
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-08-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.